Notification No. 01/2021
Date: June 2, 2021
Subject: Amendment to Notification No. 01/2017–Central Tax (Rate) to revise GST rate entries and include a COVID-19 related medicine.
Description:
This notification amends Schedule I (2.5%) by substituting the tariff heading against S. No. 259A. It also inserts Diethylcarbamazine in List 1, making it taxable at the concessional rate. The amendment was issued on the recommendation of the GST Council to rationalise rates and provide relief on essential medicines.
Issued for earlier notification?
Yes — amends Notification No. 01/2017–Central Tax (Rate).
Other Notifications
63/2019
The due date for filing FORM GSTR-1 for the months July 2019 to September 2019 i...
Read More31/2017
The due date for furnishing GSTR-6 by Input Service Distributors for July 2017 i...
Read More15/2019
This notification extends the due date for furnishing FORM GST ITC-04 in respect...
Read More